Background Annually, 4% of the global population undergoes non-cardiac surgery, with 30% of those patients having at least ...
MIT engineers have developed a tiny implantable device that could revolutionize emergency treatment for people with Type 1 diabetes. The device contains a powdered form of glucagon and can be remotely ...